ResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022
ResMed (NYSE: RMD) has announced it will release its fourth-quarter fiscal year 2022 financial results on August 11, 2022, after the NYSE closes. Following this, management will host a webcast to discuss the outcomes and other material information. The webcast will be accessible at http://investor.resmed.com. A replay will be available shortly post-webcast, including a phone replay accessible until August 25. ResMed continues to focus on innovative solutions for chronic disease management, aiming to improve quality of life and reduce healthcare costs.
- Scheduled earnings release for Q4 FY 2022 indicates ongoing financial transparency.
- The webcast discussion provides an opportunity for investors to gain insights on the company's performance.
- None.
SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2022 on Thursday, August 11, 2022, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this webcast.
Earnings webcast details:
| • Location: | http://investor.resmed.com |
| • Date: | Thursday, August 11, 2022 |
| • Time: | 1:30 p.m. PDT / 4:30 p.m. EDT |
| • International: | London, Thursday, August 11, 9:30 p.m. BST Sydney, Friday, August 12, 6:30 a.m. AEST |
Please note that ResMed does not use outside phone lines to access the earnings call.
A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from August 11 until August 25 at:
- U.S.: +1 877.660.6853
- International: +1 201.612.7415
- Conference ID: 13731513
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media |
| Amy Wakeham | Jayme Rubenstein |
| +1 858.836.5000 | +1 858.836.6798 |
| investorrelations@resmed.com | news@resmed.com |
FAQ
When will ResMed release its Q4 FY 2022 earnings results?
What is the time for ResMed's earnings webcast?
How can I access ResMed's earnings webcast?
Will there be a replay of ResMed's earnings call?
What is the purpose of ResMed's earnings webcast?
